v3 Vocabulary
In the unified registry
SubstanceAdminSubstitution
SubstanceAdminSubstitution2.16.840.1.113883.5.1070
Substance Admin SubstitutionDetails
| Name | SubstanceAdminSubstitution |
|---|---|
| Title | Substance Admin Substitution |
| OID | 2.16.840.1.113883.5.1070 |
| Concepts | 10 |
Concepts10
| Code | Display | Status |
|---|---|---|
_ActSubstanceAdminSubstitutionCode | ActSubstanceAdminSubstitutionCodeSubstitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects. | active |
BC | brand compositionECequivalent compositionSubstitution occurred or is permitted between equivalent Brands but not Generics Examples: * Zestril for Prinivil * Coumadin for Jantoven | active |
E | equivalent_ActSubstanceAdminSubstitutionCodeActSubstanceAdminSubstitutionCodeSubstitution occurred or is permitted with another bioequivalent and therapeutically equivalent product. | active |
EC | equivalent compositionEequivalentSubstitution occurred or is permitted with another product that is a: * pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester * pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: * *Pharmaceutical alternative:* Erythromycin Ethylsuccinate for Erythromycin Stearate * *Pharmaceutical equivalent:* Lisonpril for Zestril | active |
F | formulary_ActSubstanceAdminSubstitutionCodeActSubstanceAdminSubstitutionCodeThis substitution was performed or is permitted based on formulary guidelines. | active |
G | generic compositionECequivalent compositionSubstitution occurred or is permitted between equivalent Generics but not Brands Examples: * Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp) | active |
N | none_ActSubstanceAdminSubstitutionCodeActSubstanceAdminSubstitutionCodeNo substitution occurred or is permitted. | active |
TB | therapeutic brandTEtherapeutic alternativeSubstitution occurred or is permitted between therapeutically equivalent Brands but not Generics > Examples: * Zantac for Tagamet | active |
TE | therapeutic alternativeEequivalentSubstitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: * ranitidine for Tagamet | active |
TG | therapeutic genericTEtherapeutic alternativeSubstitution occurred or is permitted between therapeutically equivalent Generics but not Brands > Examples: * Ranitidine for cimetidine | active |